Sameer has over 20 years of corporate finance experience including investment banking, equity capital markets and strategic business development. Prior to joining ICR Westwicke, Sameer was the Head of the Equity Capital Markets group and a member of the senior management team at Sanford Bernstein. Sameer was responsible for investment banking coverage and equity capital markets execution and originated and executed numerous equity offerings.

At Bernstein, Sameer had a significant focus on the life sciences space and developed a successful track record in building financial sponsor, venture capital and corporate management relationships. He was actively involved in the execution of IPOs for innovative biotech companies including Alder Biopharma, Foundation Medicine, Portola Pharmaceuticals, Spark Therapeutics and Otonomy.

Prior to Bernstein, Sameer was a Director in the Corporate Finance group at Loughlin Meghji + Company (LM+Co) and played a leadership role in executing debt restructuring engagements on behalf of lenders.

Prior to LM+Co, Sameer was an Executive Director in the Financial Sponsor Group at JPMorgan, where he was responsible for coverage for some of JPMorgan’s premier financial sponsor relationships. Sameer has executed more than 25 LBO and portfolio company related transactions, which involved advising financial sponsors on LBOs worth over $50 billion and raising over $45 billion in capital. Representative transactions include the buyouts for Dunkin Brands, HCA Inc., Michael’s Stores and Domino’s Pizza.

Prior to JPMorgan, Sameer was a Senior Rating Analyst with CRISIL Ltd., which is the leading credit rating agency in India with majority ownership by Standard & Poor’s.

Sameer received his MBA from the Simon Business School, University of Rochester, MMS from the University of Mumbai (India) and BE (Production Engineering) from Shivaji University (India). He holds Series 7, 24, 63 and 79 securities licenses and lives in Summit, New Jersey with his wife and son.